Maryland 2025 Regular Session

Maryland House Bill HB529

Introduced
1/22/25  

Caption

Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars

Companion Bills

MD SB393

Crossfiled Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars

Similar Bills

MN HF5469

Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to drug with lowest out-of-pocket cost to patient.

MN HF1076

Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to the drug with the lowest out-of-pocket cost to the patient.

MN SF1876

Pharmacy benefit managers and health carriers inclusion of lower-cost drugs in formularies requirement provision and lowest out-of-pocket-cost drug to patient formulary tiering preference provision

VA HB2329

Health insurance; prescription drug formularies.

MD SB393

Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars

AR SB140

To Mandate The Use Of Biosimilar Medicines Under Health Benefit Plans; To Require A Healthcare Provider To Prescribe Biosimilar Medicines; And To Improve Access To Biosimilar Medicines.

US SB2129

Ensuring Access to Lower-Cost Medicines for Seniors Act

ME LD2114

Resolve, Directing the Superintendent of Insurance to Collect Data from Health Insurers Related to Prescription Drug Coverage of Generic Drugs and Biosimilars